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ABSTRACT
MEIS1 encodes a developmental transcription factor and has been
linked to restless legs syndrome (RLS) in genome-wide association
studies. RLS is a movement disorder leading to severe sleep
reduction and has a substantial impact on the quality of life of
patients. In genome-wide association studies, MEIS1 has
consistently been the gene with the highest effect size and
functional studies suggest a disease-relevant downregulation.
Therefore, haploinsufficiency of Meis1 could be the system with the
most potential for modeling RLS in animals. We used heterozygous
Meis1-knockout mice to study the effects ofMeis1 haploinsufficiency
on mouse behavioral and neurological phenotypes, and to relate the
findings to human RLS. We exposed the Meis1-deficient mice to
assays of motor, sensorimotor and cognitive ability, and assessed the
effect of a dopaminergic receptor 2/3 agonist commonly used in the
treatment of RLS. The mutant mice showed a pattern of circadian
hyperactivity, which is compatible with human RLS. Moreover, we
discovered a replicable prepulse inhibition (PPI) deficit in the Meis1-
deficient animals. In addition, these mice were hyposensitive to the
PPI-reducing effect of the dopaminergic receptor agonist, highlighting
a role of Meis1 in the dopaminergic system. Other reported
phenotypes include enhanced social recognition at an older age
that was not related to alterations in adult olfactory bulb neurogenesis
previously shown to be implicated in this behavior. In conclusion, the
Meis1-deficient mice fulfill some of the hallmarks of an RLS animal
model, and revealed the role of Meis1 in sensorimotor gating and in
the dopaminergic systems modulating it.
KEY WORDS: Meis1, Prepulse inhibition, Restless legs syndrome,
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INTRODUCTION
MEIS1 encodes a TALE homeobox transcription factor known to
play a role in hematopoiesis and vascular patterning (Azcoitia et al.,
2005; Carramolino et al., 2010; Hisa et al., 2004), as well as in the
development of the proximodistal limb axes (Mercader et al., 1999),
the nervous system (Barber et al., 2013; Spieler et al., 2014) and the
development of various organs, such as the heart (Mahmoud et al.,
2013), eyes (Marcos et al., 2015) and pancreas (Zhang et al., 2006).
MEIS1 cooperates with other transcription factors to perturb
myeloid differentiation in leukemogenesis (Nakamura et al.,
1996) and, in genetic association studies, it has been linked with
restless legs syndrome (RLS) (Winkelmann et al., 2007, 2011),
periodic leg movements during sleep (Moore et al., 2014;
Stefansson et al., 2007), symptoms of insomnia (Lane et al.,
2016), PR interval (Butler et al., 2012) and waist-to-hip ratio
(Shungin et al., 2015). Structurally, MEIS1 consists of a Pbx
interaction motif and a TALE homeodomain near the C-terminus,
responsible for DNA interaction. It has two major functional splice
variants, MEIS1A andMEIS1B, which diverge in the C-terminus of
the protein (Huang et al., 2005). These isoforms are differentially
expressed during development and are likely to differ in their
genomic targets and effects on neural differentiation (Maeda et al.,
2001). MEIS1 binds transcription start sites and genomic enhancers
alone and in interaction with PBX and HOX proteins, regulating the
expression of genes involved in the processes of axon guidance,
protein phosphorylation and cell differentiation, among others
(Marcos et al., 2015; Penkov et al., 2013).
RLS is a sensorimotor movement disorder causing severe sleep
loss and impaired quality of life (Trenkwalder and Paulus, 2010).
The hallmark symptoms include an urge to move the legs, relieved
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present in the evening and night time, and at rest. Epidemiological
evidence shows that RLS is more common in females compared to
males (Berger and Kurth, 2007), but the sex difference could be
explained by the number of previous pregnancies (Pantaleo et al.,
2010). In the context of RLS, MEIS1 contributes to the heritability
of the disease through both common and rare genetic variation. In
genome-wide association studies (GWAS),MEIS1 has consistently
been the gene with the largest effect size, with an odds ratio up to
1.74 (Winkelmann et al., 2007, 2011). In large-scale sequencing
and family studies, putative causal loss-of-function rare variants
have been identified (Schulte et al., 2014). A MEIS1 intronic
haplotype linked to RLS risk is associated with decreased
expression of MEIS1 (Xiong et al., 2009). Therefore, Meis1
haploinsufficiency could be considered the most promising animal
model system for human RLS. Meis1 knockout mice, in which
Meis1 has been inactivated by knocking in a modified ERT2
domain (Meis1tm1Mtor), die during development due to a fetal
hematopoietic failure (Azcoitia et al., 2005). Heterozygous animals,
however, show a hyperactive phenotype potentially compatible with
components of human RLS (Spieler et al., 2014). In addition, the
mutant animals show low fertility, low bodymass at birth and various
eye-related phenotypes (Azcoitia et al., 2005; Marcos et al., 2015).
In a bid to provide a more comprehensive understanding of the
effect of Meis1 haploinsufficiency on the central nervous system,
we exposed these heterozygous Meis1-deficient mice to a series of
motor, sensorimotor and cognitive behavioral and neurological
tests. To further disentangle what role this gene plays in the brain
and how it could be involved in RLS, we also determined the effect
of a commonly used RLS therapeutic dopaminergic receptor 2/3
(D2/3R) agonist, pramipexole, as well as performing concomitant
semi-quantitative measures of dopaminergic neuron number, iron
metabolism, believed to play an important role in the pathogenesis
of RLS, and adult neurogenesis, the birth and assimilation of new
neurons.
RESULTS
Meis1 haploinsufficiency leads to sex-dependent motor
alterations at middle age
We have shown previously (Spieler et al., 2014) that Meis1
haploinsufficiency leads to increased locomotor activity in the open
field in both male and female young adult mutant mice at the age of
9 weeks. Furthermore, these animals were hyperactive as indexed
by a tendency towards increased locomotor activity over a 21-h
period in the home-cage environment of PhenoMaster cages
(Spieler et al., 2014). In the current study, we determined whether
the severities of these effects are maintained with age. Thus,
we assessed the same locomotor activity parameters in middle-
aged mice (9-11 animals per genotype and sex) from the age of
38-40 weeks.
At this older age, Meis1 haploinsufficiency leads to locomotor
alterations that dichotomize based on sex. This was manifest as a
significant locomotor increase in the male mutant mice in the open
field, which was not evident in the females (2-way ANOVA,
sex×genotype interaction effect: F1,43=5.64, P=0.022, Fig. 1C).
Locomotor activity alterations in response to the open field could
reflect an anxiety reaction to the novelty of the arena even though
this was not evident in the anxiety-related index of center time in the
open field (2-way ANOVA, sex×genotype interaction effect:
Fig. 1. Measures of locomotor activity, motor coordination and balance.Measures of locomotor activity in the PhenoMaster cages (females: A, males: B),
open field (C) and voluntary running wheels (females D, males E), and motor coordination and balance in the rotarod (F; seconds). *P<0.05 vs +/+ controls.
(B,D)Boxes indicate an increase in activity just after lights on in the rest phase seen in female+/−mice in voluntary runningwheels (D) and inmale+/−mice in home-
cage activity (B). The cohort included 21 female (9 +/− and 12 +/+) and 23 male (10 +/− and 13 +/+) mice. Results are plotted as means±s.e.m. rev, revolutions.
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F1,43=0.16, P=0.69, genotype effect: F1,43=0.12, P=0.72, sex
effect: F1,43=0.83, P=0.37). Thus, we sought to establish whether
this hyperactivity in the male mutant mice could be confirmed with
longer-term observation in the PhenoMaster cages where the mice
are permitted to habituate to the surroundings. It is then possible to
see whether the locomotor differences are also present when
exploration is the principal behavior exhibited by the mice during
their active phase and whether it is subject to circadian variation, as
would be expected from an RLS animal model. With this analysis,
we again saw that Meis1 haploinsufficiency caused increased
locomotor activity in middle-aged males and this was evident over
several 1-h time bins, most importantly in the beginning of the
inactive phase (1-way ANOVA, genotype effect: F1,21=4.92,
P=0.038, Fig. 1B). By dividing the 21-h period into sub-phases it
transpired that the male mutant mice were hyperactive on first
transfer to the PhenoMaster cages during the habituation phase (first
3 h). Control levels of activity were then attained until after lights
off, when the male mutant mice again showed higher activity during
the active phase. The activity levels in the control male mice
continued to decrease until lights on. Nevertheless, the male mutant
mice showed another peak in activity at the start of the lights-on
phase, when the controls were at rest. The effects of Meis1
haploinsufficiency in the female mice on home-cage locomotor
activity was less pronounced (Fig. 1A). During the last hour of the
habituation phase, the female mutant mice showed increased
activity compared to controls, without major differences throughout
the remainder of the testing period.
As an additional form of locomotor activity analysis, we
measured voluntary wheel running within the home cage
(Fig. 1D,E). Each mouse was given access to a running wheel,
voluntary activity was recorded continuously and the data was
averaged over 21 days to yield a 24-h activity profile. Meis1
haploinsufficiency in the male mice did not produce differences in
the amount or pattern of voluntary running-wheel activity (Fig. 1E).
Nevertheless, the female mutant mice, although not exhibiting
marked deviations from the control profile, showed a specific
increase in activity during the first hour of the lights-on phase, when
the control mice are at rest (Fig. 1D).
As a measure of motor coordination and balance we also assessed
latency to fall from the rotarod. There was a small tendency for the
male mutant mice to show increased latencies to fall from the rod
without clear differences in the females (2-way ANOVA,
sex×genotype interaction effect: F1,39=1.431, P=0.239, genotype
effect: F1,39=0.133, P=0.294, sex effect: F1,39=0.145, P=705).
Together with our previously published findings (Spieler et al.,
2014), these data indicate thatMeis1 haploinsufficiency causes sex-,
age- and situation-dependent effects on motor restlessness in mice.
Meis1 deficiency causes sensorimotor gating deficits
without effects on thermal sensitivity
An alteration in thermal sensitivity has been shown in human
patients with secondary RLS, and intense unpleasant feelings in the
legs characterize the disease (Bachmann et al., 2010). It was thus
germane to assess sensory perception consequent to Meis1
haploinsufficiency. As a measure of thermal sensitivity, we
assessed the effect of Meis1 haploinsufficiency in the hotplate test
in mice at the younger age of 11 weeks. There were no significant
nociceptive differences detected between the genotype groups in
licking or shaking behavior, or response times (Table 1). At the age
of 10 weeks, the animals were also tested for acoustic startle
reactivity (ASR) and prepulse inhibition (PPI) of the acoustic startle
reflex. ASR was decreased in male heterozygous mutant mice with
the opposite effect in female mutants compared to controls (repeated
measures ANOVA: sex×genotype×dB interaction effect, P<0.001)
(Fig. S1). PPI was decreased in mutant mice of both sexes at 69 dB
(2-way ANOVA, genotype effect: F1,56=7.132, P=0.01, sex effect:
F1,56=0.577, P=0.45, sex×genotype interaction effect: F1,56=0.504,
P=0.48) and 73 dB (2-way ANOVA, genotype effect: F1,56=5.04,
P=0.03, sex effect: F1,56=0.206, P=0.65, sex×genotype interaction
effect: F1,56=0.767, P=0.38), as well as globally across all prepulse
intensities (2-way ANOVA, genotype effect: F1,56=5.79, P=0.019,
sex effect: F1,56=0.228, P=0.63, sex×genotype interaction effect:
F1,56=1.233, P=0.27, Fig. 2A). It was possible to replicate the effect
of Meis1 deficiency on PPI in an independent cohort of mice at the
age of 9 weeks, where again a decrease in PPI was observed at
69 dB (2-way ANOVA, genotype effect: F1,60=10.575, P=0.002,
sex effect: F1,60=10.88, P=0.0016, sex×genotype interaction effect:
F1,60=0.009, P=0.93), 73 dB (2-way ANOVA, genotype effect:
F1,60=12.227, P=0.001, sex effect: F1,60=5.74, P=0.020,
sex×genotype interaction effect: F1,60=0.024, P=0.88) and
81 dB (2-way ANOVA, genotype effect: F1,60=7.198, P=0.009,
sex effect: F1,60=9.47, P=0.0031, sex×genotype interaction effect:
Table 1. Results of the nociceptive phenotype screening (hotplate test) in our first mouse cohort
Female Male
P-valueMeis1+/+ Meis1+/− Meis1+/+ Meis1+/−
Nociception
First response time (s) 10.53±3.11 10.84±3.29 29.41±3.05 27.42±2.5 0.402
First response type: licking (no.) 8 10 4 11
First response type: shaking (no.) 7 5 11 4
Second response time (s) 14.25±3.72 14.33±3.71 13.37±2.47 13.72±1.85 0.787
Second response type: licking (no.) 7 5 11 4
Second response type: shaking (no.) 8 10 4 11
ABR
Click ABR 35 [35, 35] 42 [35, 45] 30 [25, 35] 30 [25,35] 0.285
Threshold at 6 kHz (dB) 40 [40, 44] 48 [45, 50] 40 [35, 40] 35 [35, 40] 0.104
Threshold at 12 kHz (dB) 28 [25, 34] 30 [26, 34] 20 [20, 25] 15 [15, 20] 0.612
Threshold at 18 kHz (dB) 35 [30, 40] 45 [35, 49] 30 [25, 35] 25 [20, 30] 0.908
Threshold at 24 kHz (dB) 55 [46, 59] 52 [46, 55] 40 [32, 40] 35 [30, 45] 0.876
Threshold at 30 kHz (dB) 62 [48, 70] 65 [56, 75] 50 [45, 55] 55 [45, 60] 0.115
The nociception results are presented as means±s.d. and P-values are calculated using 2-way ANOVA with sex and genotype as factors with interaction term.
The auditory brainstem response (ABR) results are presented as median [25%, 75%] and the P-values calculated with Wilcoxon rank sum test. All P-values
represent the genotype effect. n=15 per sex per genotype.
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F1,60=0.004, P=0.95) as well as globally (2-way ANOVA, genotype
effect: F1,60=13.723, P<0.001, sex effect: F1,60=9.14, P=0.0037,
sex×genotype interaction effect: F1,60=0.313, P=0.58) in both sexes
(Fig. 2B). The effect on ASR was not observed in this cohort (the
opposite effect was found) and was thus not replicable. The
assessment of ASR and PPI was not possible in the middle-aged
cohort owing to natural age-related sensorineural hearing loss,
associated with the genetic background used. The hearing loss was
not specific to either genotype group, but was seen in all mice. There
were no clear differences in auditory brainstem responses (ABRs) in
the mice of cohort 1 at 17 weeks (Table 1).
Meis1 deficiency confers insensitivity to D2/3R-agonist
effects on sensorimotor gating
Given this robust and replicable effect of Meis1 haploinsufficiency
on sensorimotor gating ability, we wanted to determine the effect of
a dopaminergic receptor agonist used in the treatment of RLS on this
phenotype. Thus, the effect of pramipexole, a preferential D2/3R
agonist, at two doses [1 and 3 mg/kg bodyweight intraperitoneal
(i.p.)] on PPI was assessed with saline vehicle control. In the
vehicle-treated mice, the mutant animals showed a higher reactivity
to acoustic startle than thewild types at higher sound intensities. PPI
was decreased in the mutant mice after vehicle injection, replicating
again the findings of the first two cohorts. The 1 mg/kg dose of
pramipexole had an effect at high sound intensities in the mutant
group, making their startle response even stronger. In the control
group, the startle response was only altered at lower sound
intensities. The 3 mg/kg dose of pramipexole, on the other hand,
increased the startle response of the wild-type mice at higher
stimulus intensities but had no effect on the mutant group. The
results are shown in Fig. S1.
PPI was affected by pramipexole in a more consistent manner. In
the wild-type group, PPI was significantly reduced by both high and
low doses of pramipexole. The PPI in these animals was reduced to
the level of the vehicle-treated mutant mice. In contrast, in the
heterozygous mutants, the PPI was not significantly altered by
pramipexole (Fig. 2C).
To investigate whether this insensitivity to the D2/3R agonist
pramipexole was influenced by the number of dopaminergic
neurons, which could lead to altered D2/3R signaling, using
optical fractionator estimates we quantified the number of tyrosine
hydroxylase (TH)-positive cells in the substantia nigra pars
compacta (SNpc) and the ventral tegmental area (VTA). We did
not observe clear differences in the total number of TH+ cells in
either the SNpc (2-way ANOVA, genotype effect: F1,12=0.401,
P=0.538, Fig. 3C) or the VTA (2-way ANOVA, genotype effect:
F1,12=0.291, P=0.599, Fig. 3F) between genotypes to indicate
that neuron number differences lead to the altered signaling.
Furthermore, we assessed iron homeostasis by measuring the
plasma levels of iron, ferritin (iron storage) and transferrin (iron
binding) (Table 2) because iron has been suggested to play a major
role in RLS pathogenesis in humans (Earley et al., 2014). There
were no clear differences between the groups in any of the three
measures except for a tendency towards a decrease in the iron-
storage protein ferritin in the female Meis1-deficient mice (2-way
ANOVA, sex×genotype interaction effect: F1,56=3.32, P=0.074).
Fig. 2. Prepulse inhibition (PPI). The PPI results from the first screening cohort (A, n=15 per sex per genotype) and the replication cohort (B, n=15 per sex
per genotype). The results show that the Meis1 knockout genotype effect on PPI was replicable when compared to wild-type littermates. Results are plotted as
means±s.e.m. Genotype effects: *P<0.05, ** P<0.005, ***P<0.001 calculated by two-way ANOVAwith sex as a factor, including interaction term. (C) The global
effect of pramipexole 1.0 mg/kg body weight (left) and 3.0 mg/kg body weight (right) on the PPI of wild-type and heterozygous animals is shown. Results are
plotted as means±s.e.m. Genotype effects: **P<0.005 calculated by two-way ANOVA with sex as a factor, including interaction term.
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Meis1 haploinsufficiency alters social memory
The olfactory social recognition index was increased in both female
and male mutant mice compared to wild types (Fig. 4A; 2-way
ANOVA, genotype effect: F1,41=9.48, P=0.004, sex effect:
F1,41=0.58, P=0.45, sex×genotype interaction effect: F1,41=1.45,
P=0.24), suggesting better social discrimination memory. There
were no genotype-related differences in social investigation time
during the sample phase of the test (data not shown). The social
recognition index showed no correlation with distance traveled in
the open field (r=−0.050, P=0.749), with time spent in the middle
of the arena (r=−0.166, P=0.282) or with total activity in the
running wheel (r=−0.073, P=0.679). None of the parameters
showed significant correlation when the sexes were tested separately
(data not shown). We have shown previously that decreased social
memory can be due to decreased adult neurogenesis in mice (Garrett
et al., 2015). Thus, to determine whether the behavioral alterations
were associated with modifications of the adult neurogenesis in
Meis1-deficient mice, a stereological approach was used to quantify
the number of doublecortin (DCX)-positive cells in the granular cell
layer of the olfactory bulb (Fig. 4B). DCX expression is an
immature neuron marker in the adult brain that has also been shown
to reflect overall levels of neurogenesis, and DCX+ cell
quantification can be used as an alternative to BrdU pulse/chase
analysis (Couillard-Despres et al., 2005). Optical fractionator
estimates showed that there was no significant effect of genotype
on the number of DCX+ cells in the granular cell layer of the
olfactory bulbs in these mice (unpaired t-test: t10=0.401, P=0.697).
DISCUSSION
Haploinsufficiency of Meis1 is a potential model system for
simulating RLS in mice. Here, we show that this Meis1 deficit
causes a sex- and context-dependent RLS-related phenotype at
middle age, impaired sensorimotor gating ability that was refractory
to the D2/3R agonist pramipexole as well as increased social
memory. These behavioral abnormalities occurred without
differences in thermal sensitivity, plasma iron concentrations or
dopaminergic neuron number in the SNpc/VTA. Thus, although
Meis1 haploinsufficiency causes the RLS-related phenotype of
motor restlessness in mice, the detailed nature of these effects is
complex. Furthermore, it is characteristically distinct from other
genetic RLS models (e.g. Btbd9 knock-out), highlighting the
heterogeneous nature of the effects of these different risk genotypes
in this disease.
Motor restlessness in these Meis1-haploinsufficient mice was
detected previously in young adult male and female mice (Spieler
et al., 2014). RLS is, however, more prevalent at an older age in
humans (Berger et al., 2004) and therefore we also tested middle-
aged mice. Human RLS occurs in a circadian fashion where the
patients are typically affected in the evening hours, and therefore a
circadian hyperactivity pattern specific to the beginning of the
inactive period should be expected from an RLS animal model. So,
althoughwe have shown here that the overall locomotor effects in the
open field and PhenoMaster cages deviate per the sex of the animal in
middle age, both the male and femaleMeis1-haploinsufficient mice
still show such an RLS-like phenotype: specific increases in activity
Fig. 3. Dopaminergic neurons. Tyrosine hydroxylase (TH)+ neurons in the substantia nigra pars compacta (SNpc; A,B) and ventral tegmental area
(VTA; D,E) of wild-type (+/+) and heterozygous knockout (+/−) mice. Scale bars: 100 µm. (C,F) Results are plotted as means±s.e.m. No differences were
found between the groups in either the SNpc (C) or VTA (F). Groups are n=3 male +/+, n=4 male +/−, n=4 female +/+, n=5 female +/−.
Table 2. Results of the analysis of levels of iron, ferritin and transferrin in the plasma from wild-type and heterozygous mice
Female Male Linear model P-value
Meis1+/+ Meis1+/− Meis1+/+ Meis1+/− Genotype Sex Sex × genotype
Iron (μmol/l) 27.4±4.6 26.8±6.5 17.4±2.5 17.6±2.4 0.875 <0.001 0.721
Ferritin (pmol/l) 326.6±62.6 284.5±47.1 239.4±36.3 240.9±33.6 0.096 <0.001 0.074
Transferrin (μmol/l) 18.97±0.53 19.01±0.58 18.72±0.31 19.02±0.3 0.158 0.293 0.275
No clear differences were detected between the groups for each parameter measured. The results are presented as means±s.d. n=15 per sex per genotype.
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during the initial stage of the rest phase. In the males, this occurs in
the PhenoMaster cages and, in the females, in their voluntary wheel-
running activity pattern. In males, however, hyperactivity is also
observed during the active period, making the effect less specific to
the RLS-relevant time bins. Meis1-haploinsufficiency thus leads to
RLS-like circadian motor restlessness in middle age that, in the case
of the females, requires amplification with an additional
environmental stimulus. The latter could represent the urge to
move, a key feature of human RLS. This outcome further reveals that
RLS associated with Meis1 risk haplotypes is likely to produce
sexually dimorphic motor effects in middle age.
In terms of sensory function, the Meis1 deficiency did not alter
thermal sensitivity in response to the hotplate, which is incongruous
with the effects in the Btbd9 mouse RLS model (DeAndrade et al.,
2012). Nevertheless, augmented thermal sensitivity is a feature of
patients with secondary RLS, whereas patients with idiopathic RLS
experience different types of sensitivity (Bachmann et al., 2010).We
also report here the first evidence to indicate that a Meis1 deficit
leads to a reproducibly decreased PPI response. This deficit occurs in
the absence of ABR alterations, suggesting that the PPI phenotype is
not secondary to impaired hearing in the mice. PPI of the acoustic
startle reflex is a commonly used rodent readout for sensorimotor
gating and integration. Impairment of PPI has been observed in
neurological disorders (Kohl et al., 2013) and it is most frequently
used as a readout in schizophrenia research (Swerdlow and Light,
2015). PPI was not altered in the single study conducted in RLS
patients so far (Leon-Sarmiento et al., 2015). However, the patients
were not stratified by their MEIS1 genotype in that study and it is
possible that PPI is a phenotype specific to RLS associated
with Meis1 risk haplotypes. This prospect is also supported by the
lack of PPI differences in homozygous Btbd9-knockout mice
(Btbd9tm1b(EUCOMM)Wtsi) (Meehal et al., 2017; see also: www.mouse
phenotype.org/data/experiments?geneAccession=MGI:1916625).
Thus, PPI should be studied in RLS patients who also are carriers of
the MEIS1 risk allele.
In our treatment experiment, pramipexole, a D2/3R agonist, did
not rescue the PPI phenotype in Meis1-deficient mice. On the
contrary, it reduced the PPI in wild-type mice to the level of the
mutants. The effect of pramipexole on wild-type mice contradicts an
earlier study reporting no pramipexole effect on PPI in C57BL/6
mice (Chang et al., 2010). However, theMeis1-deficient mice were
bred on a C57BL/6JOlaHsd substrain background and this different
outcome could be explained by the high strain sensitivity of the
dopaminergic effect on PPI (Swerdlow et al., 2004). The lack of
effect on the mutant animals might indicate that theMeis1-deficient
mice are hyposensitive to pramipexole, which may signify the
involvement of Meis1 in the dopaminergic system. It has been
demonstrated in neuropathological studies that there is a higher level
of TH, the dopaminergic synthetic enzyme, in the substantia nigra of
RLS sufferers and fewer D2 receptors in the putamen correlated
with RLS severity (Connor et al., 2009). Thus, given that PPI is
regulated by dopaminergic systems of the nucleus accumbens and
striatum (Swerdlow et al., 2001), to test whether it may be a
causative factor in the insensitivity to pramipexole in these mice we
quantified the number of TH+ neurons in the SNpc and VTA.
Nevertheless, our results did not indicate significant differences in
the numbers of dopaminergic neurons in these areas. It remains
possible that the expression of dopamine receptors is reduced
Fig. 4. Behavioral alterations are not associated with modifications of adult neurogenesis in Meis1-deficient mice. (A) Social recognition test revealed
an increased social recognition index in themutant animals compared towild types. The cohort included 21 female (9 heterozygous and 12wild-type) and 23male
(10 heterozygous and 13 wild-type) mice. **P<0.01, 2-way ANOVA genotype effect: F1,41=9.48, P=0.004, Meis1+/+ vs Meis1+/−. (B) No clear differences
were detected in the level of adult neurogenesis in the olfactory bulb granular cell layer (OB) of the mutant mice as indexed by the number of doublecortin
(DCX)+ cells in this region. Data from males and females were pooled for this analysis (n=6 +/+, n=6 +/−). Results are plotted as means±s.e.m. Representative
photomicrographs are also depicted showing DCX+ cells (black arrowheads) in the OB of wild type (+/+) and heterozygous mutant (+/−) mice. Scale bars:
100 µm.
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in Meis1-deficient mice and this will require further study.
There were also no differences in plasma iron homeostasis. This
again distinguishes the Meis1-haploinsufficient mice from the
Btbd9 mice, where the latter also shows decreased serum iron
levels (DeAndrade et al., 2012). Nevertheless, the Btbd9 mice
did not show differences in brain-tissue iron levels. Thus, it
would be propitious to quantify striatal iron levels in these
Meis1-deficient mice.
We have shown here, for the first time, a non-sensorimotor
cognitive phenotype associated with Meis1 deficiency. The Meis1-
deficient mice had improved social memory as indexed by enhanced
social recognition ability. There is limited conflicting evidence
available concerning the cognitive ability of RLS patients with
reports of deficits (Kim et al., 2014), enhanced ability (Moon et al.,
2014) and no alterations in different types of memory (Driver-
Dunckley et al., 2009; Fulda et al., 2010). These inconsistencies
could relate to the type of memory assessed, the age and sex of the
patient, the type of RLS (idiopathic versus secondary), medication
status and, as previously alluded, patients in these studies have not
been stratified according to risk haplotypes. Moon and colleagues
have shown that drug-naïve idiopathic RLS patients, predominantly
at middle age, exhibit enhanced verbal fluency and word memory
(Moon et al., 2014). They conjectured that this increased ability may
be an adaptation to sleep disturbance manifesting as heightened
alertness with an unknown underlying mechanism. We have
demonstrated previously involvement of adult neurogenesis in
social discrimination memory in the DCXCreERT2; DTA model
where loss of DCX+ cells and hence decreases in adult neurogenesis
reversibly impaired social recognition memory (Garrett et al.,
2015). Therefore, given the impaired social recognition memory, we
hypothesized that abnormal neurogenesis in the olfactory bulbs of
Meis1-deficient mice may underlie this deficit. Our quantification
of DCX+ cells in the olfactory bulb did not, however, support this
hypothesis and no differences were observed. This indicates that
alternative processes likely mediate the enhanced social memory
consequent to Meis1 deficiency. Recent evidence showing zonal
Meis1 expression in the main olfactory epithelium could signify one
potential avenue for further investigation in this regard (Parrilla
et al., 2016). Furthermore, in light of this new evidence, a more
detailed analysis of cognitive ability in RLS patients with theMEIS1
risk haplotype is warranted.
In summary, Meis1-deficient mice show an RLS-like motor-
restlessness phenotype, a sensorimotor gating deficiency refractory
to a D2/3R agonist and some heretofore unknown Meis1-
deficiency-related effects. Other proposed RLS-related genetic
mouse models such as Btbd9 (DeAndrade et al., 2012) and Ptprd
(Drgonova et al., 2015) exhibit degrees of motor restlessness. There
are features of Meis1-deficient mice, however, that are distinct and
could be explained by the genetic architecture of the disease. For
example, when a motor phenotype (periodic leg movements during
sleep) is used to assess RLS in human genetic studies, the BTBD9
locus has the highest effect size (Moore et al., 2014; Stefansson
et al., 2007). When the sensory RLS symptoms are assessed, the
MEIS1 locus is the top hit (Winkelmann et al., 2007, 2011). This
indicates that the specific disease characteristics in patients will
depend on the combination of risk alleles at different genetic risk
loci and this is supported by the current data. RLS is a genetically
heterogeneous complex trait with high prevalence but large
phenotypic variability, and both idiopathic and secondary forms
contribute to prevalence statistics. Thus, fine-mapping and further
genetic studies in RLS patients may reveal differential effects of the
various risk loci as observed in these mice and in other studies. In
future investigations, an RLS-related mutation within Meis1 may
provide a more disease-relevant disruption of Meis1 function in
mice and therefore a better RLS phenotype (Allen et al., 2017).
MATERIALS AND METHODS
Animals and breeding
The Meis1tm1Mtor mice used in the experiments were created in Madrid,
Spain (Azcoitia et al., 2005) and have been bred on the C57BL/6JOlaHsd
(Envigo, Horst, The Netherlands) background. In this strain,Meis1 has been
inactivated by knocking in a modified ERT2 domain. The result is predicted
to encode an inactive protein product. The mouse line has been bred in
Munich, Germany, backcrossing to wild-type C57BL/6JOlaHsd every
generation. Mouse husbandry was performed according to the FELASA
recommendations (Nicklas et al., 2002) (http://www.felasa.eu) in a
controlled specific pathogen free (SPF) hygiene standard environment.
The mice had access to ad libitum standard feed and water always. All tests
were carried out with approval for the ethical treatment of animals by the
responsible authority of the Regierung von Oberbayern (Government of
Upper Bavaria).
Analysis of Meis1tm1Mtor mice
Four different mouse cohorts were bred for the experiments described here
and the corresponding tests and order performed are shown in Fig. 5. In all
experiments, heterozygous animals (Meis1+/−) were used, homozygotes
being embryonic lethal (Azcoitia et al., 2005). The mice from the different
cohorts were tested together with their wild-type (Meis1+/+) littermates as
control animals for behavioral/neurological measures as follows: cohort 1
(15 male +/+, 15 male +/−, 15 female +/+ and 15 female +/−) were tested in:
open field (at 9 weeks; published in Spieler et al., 2014); prepulse inhibition
(at 10 weeks); hotplate (at 11 weeks); locomotor activity in PhenoMaster
cages (at 12 weeks; published in Spieler et al., 2014); plasma iron level
analysis (at 16 weeks); and ABR (at 17 weeks); cohort 2 (10 male +/−, 13
male +/+, 9 female +/−, 12 female +/+) were tested in: open field (at 38-
40 weeks); PPI (at 39-41 weeks); rotarod (at 44-46 weeks); locomotor
activity in the PhenoMaster cages (at 41-43 weeks); locomotor activity in
running wheels (at 48-50 weeks); and social discrimination (at 51-
53 weeks); cohort 3 (15 male +/+, 15 male +/−, 15 female +/+ and 15
female +/−) were tested for: PPI (at 9 weeks), and a subset of these animals
were perfused with paraformaldehyde (PFA) and used for brain-tissue
stereological analysis of dopaminergic neuron number (TH+ cells) and adult
neurogenesis (DCX+ cells). The mice (30 animals per sex per genotype)
from cohort 4 were tested for sensitivity to pramipexole in PPI (at 10 weeks
for 1 mg/kg body weight and at 11 weeks for 3 mg/kg body weight). Mice
from the first cohort also underwent the standardized phenotype screening at
the German Mouse Clinic (GMC; www.mouseclinic.de). The test battery
included additional screening of the mice in the areas of dysmorphology,
clinical chemistry, energy metabolism, cardiovascular studies, eye function,
immunology, allergy, steroid metabolism, lung function and pathology. The
screens were performed as described in previous publications (Fuchs et al.,
2009; Gailus-Durner et al., 2005, 2009) and the results of this analysis can
be found on the GMC phenomap (tools.mouseclinic.de/phenomap/jsp/
annotation/public/phenomap.jsf ).
Open field
The open-field analysis was carried out as we described previously (Garrett
et al., 2012; Hölter et al., 2013; Zimprich et al., 2014). It consisted of a
transparent and infrared-light-permeable acrylic test arena with a smooth
floor (internal measurements: 45.5×45.5×39.5 cm). Illumination levels
were set at approx. 150 lux in the corners and 200 lux in the middle of the
test arena. Data were recorded and analyzed using the ActiMot system (TSE,
Bad Homburg, Germany).
PPI of the ASR
Mice were housed with food and water available ad libitum under standard
laboratory conditions. Animals were separated based on sex, but not
genotype. PPI was assessed using a startle apparatus setup (Med Associates
Inc., VT, USA) including four identical sound-attenuating cubicles. The
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protocols were written using the Med Associates ‘Advanced Startle’
software. Experiments were carried out between 08:30 h and 17:00 h.
Background noise was 65 dB, and startle pulses were bursts of white noise
(40 ms). A session was initiated with a 5-min acclimation period followed
by five presentations of leader startle pulses (110 dB) that were excluded
from statistical analysis. Trial types for the PPI included four different
prepulse intensities (67, 69, 73, 81 dB); each prepulse preceded the startle
pulse (110 dB) by a 50-ms inter-stimulus interval. Each trial type was
presented ten times in random order, organized in ten blocks, each trial type
occurring once per block. Inter-trial intervals varied from 20 to 30 s. This
protocol is based on the protocol used in IMPRESS from the IMPC (see
www.mousephenotype.org/impress), adapted to the specifications of our
startle equipment.
Drug preparation
Pramipexole (pramipexole dihydrochloride, Sigma Aldrich, St Louis, MO,
USA) was prepared in saline and injected at two different doses (1 and
3 mg/kg body weight). For the PPI test with drug treatment, Meis1 and
control mice were assigned to receive either pramipexole (1 and 3 mg/kg
body weight) or saline vehicle and this was balanced for genotype, startle
chamber and treatment. The mice were tested for PPI 1 h after administration
of the treatment and the i.p. injection volume was 10 ml/kg body weight.
The experimenter was not blinded during the PPI testing as the test is
automated and there was no possibility for observer bias.
ABR
ABR measurements were performed using an RP2.1 workstation (Tucker-
Davis Technologies, FL, USA) as previously described (Lee et al., 2015). In
short, animals were anesthetized and electrodes were placed on the vertex
(reference) and ventrolateral to the ears (active and ground) of the animals.
ABR potentials, as responses to broadband clicks or pure-tone frequencies,
were recorded. Frequencies ranged from 6 to 30 kHz with a 6 kHz stepping,
and sound pressure levels ranged from 0 to 85 dB with 5 dB steps. Hearing
thresholds were determined for each frequency as the lowest sound pressure
level (SPL) producing a measurable ABR pattern response.
Hotplate
In nociception, mice were screened using a hotplate assay. A mouse was
placed on a 28-cm-diametermetal surfacemaintained at 52+0.2°C surrounded
by a 20-cm-high Plexiglass wall (TSE, Bad Homburg, Germany). Mice
remained for 30 s on the plate or until they performed one of three behaviors
regarded as indicative of nociception: hind-paw licking, hind-paw shake/
flutter or jumping. The latency of the first sign of pain was compared.
Social discrimination
The social discrimination procedure consisted of two 4-min exposures of
stimulus animals (ovariectomized 129Sv females) to the test animal in a
fresh cage to which the test animal had been moved 2 h prior to testing.
During the first exposure, one stimulus animal was exposed to the test
animal. After a retention interval of 2 h, this stimulus animal was re-exposed
to the test animal together with an additional, not previously presented
stimulus animal. The duration of investigatory behavior of the test animal
towards the stimulus animals was recorded by a trained observer with a
hand-held computer. A social recognition index was calculated as time spent
investigating the unfamiliar stimulus mouse/time spent investigating both
the familiar and unfamiliar stimulus mouse.
Fig. 5. An overviewof the four cohorts ofmice used and the age at which each of the tests were performed. Three young-adult and onemiddle-aged cohort
was used. Results from additional German Mouse Clinic (GMC) screening can be found at the GMC phenomap (www.mouseclinic.de).
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The rotarod (Bioseb, Chaville, France) was used to measure forelimb and
hindlimb motor coordination, balance and motor learning ability. The
machine was set up in an environment with minimal stimuli such as noise
and movement. The rotarod device is equipped with a computer-controlled
motor-driven rotating rod. The unit consists of a rotating spindle and five
individual lanes, one for each mouse. In general, the mouse is placed
perpendicular to the axis of rotation, with head facing the direction of the
rotation. All mice were placed on the rotarod at an accelerating speed from 4
to 40 rpm for 300 s with 15 min between each trial. In motor-coordination
testing, mice were given four trials at the accelerating speed in one day. The
mean latency to fall off the rotarod during the trials was recorded and used in
subsequent analysis. Before the start of the first trial, mice were weighed.
Locomotor activity in PhenoMaster cages
For the evaluation of home-cage locomotor activity, single micewere kept in
respirometry cages (PhenoMaster System, TSE Systems, Germany) (Gailus-
Durner et al., 2009). The measurement started at 13:00 h (CET) after a 2-h
adaptation to the cages and continued until 10:00 h the next morning. The
setup allowed the analysis of locomotor activity of individual mice every
20 min, resulting in 63 readings per individual and trial. Two infrared-light-
beam frames allowed the monitoring of physical activity (lower frame:
distance traveled per 20 min, upper frame: number of rearings per 20 min).
Voluntary wheel running
All mice were singly housed and provided with an angled running wheel
(diameter 15.50 cm) complete with a wireless-controlled activity counter
(Wheel Manager software, Med Associates Inc., VT, USA) for 21 days.
Plasma iron level analysis
Blood samples were collected in the morning at 14 or 15 weeks of age by
retrobulbar puncture under isoflurane anesthesia. Determination of clinical
chemistry parameters in heparinized plasma samples was done using an
AU480 (Beckman-Coulter, Krefeld, Germany) and reagent kits provided by
Beckman-Coulter, as described previously (Rathkolb et al., 2013).
Hematological analyses were performed with an ABC animal blood
counter (Scil animal care company, Viernheim, Germany) on whole-blood
samples collected in EDTA-coated tubes.
Tissue preparation
Animals were deeply anesthetized using CO2 and perfused transcardially
with 4% PFA in 0.1 M phosphate buffer. Brains were dissected from the
skulls, post-fixed overnight in 4% PFA at 4°C and then transferred to a 30%
(w/v) sucrose solution until saturated. Brains were then sectioned on a dry-
ice-cooled block with a sliding microtome (Leica, Bensheim) into 40-µm-
thick coronal free-floating sections and stored at −20°C in a cryoprotectant
solution containing 25% ethylene glycol and 25% glycerine in phosphate
buffer. A one-in-six series of sections was taken for analysis from the brains
of a subset of animals from each group.
Immunostaining
For immunostaining of DCX and TH, an Avidin-Biotin Complex (ABC)
method like that employed previously (Garrett et al., 2012) was used. For the
DCX staining, a primary rabbit polyclonal anti-DCX antibody (1:500,
Abcam, cat. no: ab18723) was used on this occasion with a biotinylated goat
anti-rabbit IgG (1:300; Jackson ImmunoResearch Laboratories Inc.) and
3,3′-diaminobenzidine (DAB) as the chromogen. For the TH staining, a
primary rabbit anti-TH antibody (1:1000, Pel-Freeze, cat. no: P40101) was
used with a biotinylated goat anti-rabbit IgG (1:300; Jackson
ImmunoResearch Laboratories Inc.) and DAB as the chromogen.
Quantification of TH+ and DCX+ neurons
Estimation of the total number of TH+ and DCX+ cells was determined
using a method based on the stereological optical fractionator principle
and the semiautomatic StereoInvestigator system (MicroBrightField Inc.,
Williston, VT, USA). For TH+-cell estimation, the SNpc and VTA were
traced in every 6th section. For DCX+-cell estimation, the olfactory bulb
granular cell layer (OB) was traced in every 6th section. Immunopositive
cells were quantified by systematic random sampling using the following
settings: TH+ cells in the SNpc and VTA: a scan grid size of 200×200 µm
and a counting frame size of 70×70 µm; DCX+ cells in the OB: a scan
grid size of 200×200 µm and a counting frame of 100×100 µm. Cells
that intersected the uppermost focal plane or the lateral exclusion
borders of the counting frame were not quantified. These settings were
sufficient to keep the Gundersen coefficient of error (m=1) less than 0.1
for each animal.
Statistics
Tests for genotype effects were done either by using t-test, Wilcoxon rank
sum test, linear models or ANOVA. The choice of the method depended on
the assumed distribution of the parameter and the nature of the question
posed to the data. Correlations in the aged cohort were evaluated using
Pearson correlation coefficient. A P-value of 0.05 was used as level of
significance without correction for multiple testing. The analyses were
performed using the programming language R (version 3.0.2).
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Christoph Lengger, Holger Maier, Claudia Stoeger, Stefanie Leuchtenberger,
Valérie Gailus-Durner, Helmut Fuchs and Martin Hrabě de Angelis.
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Garrett, L., Lie, D., Hrabé de Angelis, M., Wurst, W. and Hölter, S. M. (2012).
Voluntary wheel running in mice increases the rate of neurogenesis without
affecting anxiety-related behaviour in single tests. BMC Neurosci. 13, 61.
Garrett, L., Zhang, J., Zimprich, A., Niedermeier, K. M., Fuchs, H.,
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Supplemental figure 1. The acoustic startle response results from the first screening cohort (A, n=15 per sex 
per genotype) and the replication cohort (B, n=15 per sex per genotype). The results show that the Meis1 
knock-out genotype effect on ASR was not replicable when compared to wildtype littermates. Results are 
plotted as mean +SEM. Genotype effects * p<0.05, ** p<0.005, *** p<0.001 calculated by two-way ANOVA 
with sex as a factor, including interaction term. The effect of pramipexole 1.0 mg/kg (left) and 3.0 mg/kg 






























(right) on the ASR of wildtype and heterozygous animals is shown (E, F) with corresponding baseline 
measurements (C, D). Results are plotted as mean +SEM. Genotype effects * p<0.05, ** p<0.005, *** 
p<0.001 calculated by two-way ANOVA with sex as a factor, including interaction term. 
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First Person is a series of interviews with the first authors of a 
selection of papers published in Disease Models & Mechanisms, 
helping early-career researchers promote themselves alongside 
their papers. Aaro Salminen and Lillian Garrett are first author on 
‘Meis1: effects on motor phenotypes and the sensorimotor system 
in mice’, published in DMM. Dr Salminen is a post-doc at the 
Institute of Neurogenomics at Helmholtz Zentrum München, with 
a primary focus on modeling human neurological diseases in mice 
and a special interest in restless legs syndrome. Dr Garrett is part 
of the German Mouse Clinic and Institute of Developmental 
Genetics at the Helmholtz Zentrum München and interested in the 
behavioral and brain abnormalities associated with neurological 
and neuropsychiatric disease. 
How would you explain the main findings of your paper to 
non-scientific family and friends? 
Restless legs syndrome (RLS) is a common neurological disorder 
characterized by uncomfortable sensations in the limbs, usually at 
rest, with an urge to move the legs. RLS is highly hereditary and 
there is data from human studies suggesting that mutations in a gene 
called Meis1 may be involved in causing this disorder. Thus, our 
goal was to reproduce the symptoms that individuals with RLS 
experience in a mouse model where Meis1 is genetically modified. 
We showed that mutant mice were more active than the control 
animals in the beginning of their sleep period. This is similar to RLS 
symptoms in humans, which occur in the evening time. Furthermore, 
we established that this mutation can cause other potentially 
debilitating changes in behavior that, in the interests of improving 
quality of life, should be assessed in individuals with a Meis1 
mutation. 
What are the potential implications of these results for 
your field of research? 
Most importantly, we show that knocking out Meis1 produces an 
RLS-like phenotype in mice at an older age. In addition, the methods 
we used have the potential to point the RLS community towards 
better phenotyping approaches in investigating other potential RLS 
animal models. Moreover, the phenotypic differences that we see 
between these Meis1 haploinsufficient mice and other genetic 
models of RLS highlight the necessity to stratify individuals with 
RLS according to their risk haplotypes when considering treatment 
options.  
“Since the diagnosis of RLS is based on an 
interview, with no objective markers found in 
humans, developing animal readouts is 
challenging” 
What are the main advantages and drawbacks of the model 
system you have used as it relates to the disease you are 
investigating?  
We used heterozygous Meis1 knockout mice in our studies. Meis1 is 
the highest-confidence gene associated with RLS in humans, with its 
downregulation linked to development of the disease. Therefore, the 
main advantage is its close relation to the human disease on a 
molecular level. The main disadvantage is the lack of established 
RLS readouts in animal models. Since the diagnosis of RLS is based 
on an interview, with no objective markers found in humans, 
developing animal readouts is challenging. 
What has surprised you the most while conducting your 
research? 
Given the genetic complexity of the disorder, it was surprising that 
haploinsufficiency in one RLS-related gene can already lead to 
features reminiscent of those observed in humans. 
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Describe what you think is the most significant challenge 
impacting your research at this time and how will this be 
addressed over the next 10 years? 
The major challenge in the development of an RLS animal model is  
the lack of disease-specific readouts. RLS symptoms in humans are 
subjective and therefore difficult to mimic in animals. Development 
of new animal phenotyping methods and finding a consensus within 
the scientific community focusing on RLS about essential criteria for 
an RLS animal model will be important in the next few years. 
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